Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


SMi - 4th Annual Biosimilars & Biobetters

01 Oct 2013 - 02 Oct 2013 - London, UK



Bookmark and Share


Building unto the success of last year, Biosimilars & Biobetters 2013 will showcase how biological therapeutics promises to be a radical step forward for many pharmaceutical companies pipelines, looking at how patent expiry dates are playing an important role in why many Pharma companies are pushing for innovative steps to be taken in this field.

The agenda aims to bring together pharma, biotech, CROs with regulatory bodies and legal experts explaining the advantages and disadvantages within this growing market, looking at case studies from those who are developing and distributing follow on biologics with analysis of key trends in biologic pipelines, methods in clinical trials for biosimilar approval, a review of emerging markets, assessment of biosimilar manufacturing, post approval strategy and future forecasting for follow on biologics.

KEY REASONS TO ATTEND

Discover guidelines issues by regulatory bodies such as the FDA & EMEA and how they impact your business model

Understand market access pathways and see case studies on successful products

Hear development processes from preclinical focussed research from big pharma companies

Learn from expert legal opinions on intellectual property and patent protection programmes

Evaluate global research co-operation producing blockbuster Biosimilars

Develop clinical plan for biosimilar and biobetter drug design for your clinical trial - When is the right time to proceed

HOW TO BOOK

Visit our website here: www.smi-online.co.uk/goto/2013biosimilars-biobetters11.asp

Alternatively, contact Fateja Begum on +44 (0)20 7827 6184 or email: fbegum@smi-online.co.uk

Academic & Group discounts available



Further information
Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!